SOPHiA GENETICS S.A.
SOPH | NASDAQ
$7.10
-$0.53 (-6.95%)
Nov 2, 2026, 2:08 PM ET · Market open
Company Profile
SOPHiA GENETICS S.A. operates as a specialized company within the healthcare technology sector. The firm provides the SOPHiA DDM platform, a cloud-native Software-as-a-Service (SaaS) solution engineered to analyze diverse multimodal datasets and various diagnostic inputs, thereby extracting valuable insights. This platform, together with its related offerings and services, is widely adopted by hospitals, laboratories, and biopharmaceutical organizations across the globe. Founded in 2011, SOPHiA GENETICS S.A. is headquartered in Saint-Sulpice, Switzerland.
Key Executives
| Name | Position |
|---|---|
| Ross Jordan Muken | CEO & Director |
| Abhimanyu Verma | EVP & Chief Technology Officer |
| George A. Cardoza | Executive Vice President & Chief Financial Officer |
| Manuela Da Silva Valente | Executive Vice President & Chief People Officer |
| Daan van Well | Executive VP and Chief Legal & Compliance Officer |
| Jurgi Camblong | Co-Founder & Executive Chairman |
| Kellen Sanger | Head of Strategy and Investor Relations |
| Kevin Puylaert | SVP & Chief Sales Officer |
| Philippe Menu | Executive Vice President, Chief Medical Officer & Chief Product Officer |
| Zhenyu Xu | Executive Vice President & Chief Scientific Officer |
SOPHiA GENETICS S.A.
| Country | Switzerland |
| IPO Date | Jul 23, 2021 |
| Industry | Medical - Healthcare Information Services |
| Sector | Healthcare |
| Employees | 415 |
| CEO | Ross Muken |
Contact Details
La Piece 12 Rolle,
VD 1180 Switzerland
Stock Details
| Ticker Symbol | SOPH |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001840706 |
| CUSIP Number | H82027105 |
| ISIN Number | CH1125843347 |
| SIC Code | 2836 |
Add to Watchlist
Select watchlists to add or remove SOPH